pyroglutamate rongliflozin capsules

DRUG2 trials

Sponsors

Sunshine Lake Pharma Co., Ltd.

Conditions

Diabetes Mellitus, Type 2Type 2 Diabetes

Phase 1

A Study of the Pharmacokinetics, Pharmacodynamics, and Safety of Rongliflozin in Type 2 Diabetic Subjects With Renal Impairment

CompletedNCT05374343

Sunshine Lake Pharma Co., Ltd.Type 2 Diabetes

Start: 2022-05-05End: 2023-08-24Updated: 2026-04-30

A Clinical Trial to Evaluate the Pharmacokinetics and Safety of Pyroglutamate Rongliflozin Capsules in Subjects With Mild and Moderate Liver Damage

CompletedNCT05427682

Sunshine Lake Pharma Co., Ltd.Diabetes Mellitus, Type 2

Start: 2022-04-19End: 2023-11-10Updated: 2026-05-05